John G Gribben Selected Research

Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)

1/2015	High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution.
7/2014	Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.
7/2011	A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.
4/2011	Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.
9/2008	Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
3/2008	Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
10/2005	Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias.
8/2004	ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
7/2002	Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John G Gribben Research Topics

Disease

61	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 07/2002
50	Neoplasms (Cancer) 01/2022 - 01/2002
26	Lymphoma (Lymphomas) 01/2022 - 03/2002
18	Leukemia 01/2022 - 10/2004
17	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 11/2006
10	Disease Progression 01/2022 - 08/2004
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 01/2002
9	Residual Neoplasm 01/2022 - 12/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2002
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2012
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2006
5	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 04/2012
5	B-Cell Lymphoma (Lymphoma, B Cell) 10/2016 - 07/2013
4	Hematologic Neoplasms (Hematological Malignancy) 10/2016 - 03/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2015 - 12/2003
3	Multiple Myeloma 01/2022 - 06/2002
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 03/2002
2	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2005
2	Infections 10/2019 - 11/2018
2	Neutropenia 10/2019 - 11/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 07/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2006 - 01/2002
1	Hypertension (High Blood Pressure) 01/2022
1	Tertiary Lymphoid Structures 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Tumor Lysis Syndrome 01/2020
1	Leukopenia 10/2019
1	Sudden Death 01/2019
1	Carcinogenesis 01/2019
1	Neuroendocrine Carcinoma 01/2019
1	Crohn Disease (Crohn's Disease) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018

Drug/Important Bio-Agent (IBA)

15	Rituximab (Mabthera)FDA Link 02/2021 - 03/2002
10	AntigensIBA 01/2017 - 09/2002
10	Immunoglobulins (Immunoglobulin)IBA 04/2009 - 03/2002
9	obinutuzumabIBA 01/2022 - 08/2016
9	Lenalidomide (CC 5013)FDA Link 10/2019 - 09/2009
9	fludarabineIBA 11/2018 - 02/2004
9	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2015 - 07/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018 - 03/2002
7	ibrutinibIBA 01/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 10/2020 - 03/2008
6	Chlorambucil (Leukeran)FDA Link 01/2022 - 04/2014
5	LigandsIBA 10/2016 - 08/2012
4	Pharmaceutical PreparationsIBA 01/2022 - 07/2008
4	Phosphotransferases (Kinase)IBA 01/2022 - 02/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 03/2002
4	Monoclonal AntibodiesIBA 03/2009 - 01/2002
3	venetoclaxIBA 01/2020 - 01/2019
3	HMGB1 Protein (HMG1)IBA 01/2019 - 03/2014
3	Bendamustine Hydrochloride FDA Link 01/2018 - 08/2016
3	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 06/2005
3	Isoantigens (Alloantigen)IBA 01/2016 - 09/2008
3	Vincristine (Oncovin)FDA LinkGeneric 09/2015 - 03/2002
3	Prednisone (Sone)FDA LinkGeneric 09/2015 - 03/2002
3	Proteins (Proteins, Gene)FDA Link 06/2014 - 01/2003
3	AntibodiesIBA 05/2013 - 08/2008
3	Alemtuzumab (Campath)FDA Link 01/2011 - 07/2006
2	Chimeric Antigen ReceptorsIBA 01/2022 - 12/2013
2	EnzymesIBA 01/2022 - 06/2015
2	Immunoglobulin Variable RegionIBA 12/2020 - 03/2007
2	AnthracyclinesIBA 10/2020 - 04/2012
2	CytokinesIBA 01/2018 - 01/2003
2	Biological ProductsIBA 01/2013 - 07/2008
2	Bortezomib (Velcade)FDA Link 01/2012 - 11/2008
2	Actins (F Actin)IBA 09/2010 - 11/2009
1	axicabtagene ciloleucelIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2021
1	Gemcitabine FDA Link 01/2021
1	ChemokinesIBA 01/2021
1	Estrogen ReceptorsIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 10/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2020
1	Tamoxifen FDA LinkGeneric 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	CateninsIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	ethyl pyruvateIBA 01/2019
1	serum P-component (CIt)IBA 11/2018
1	ofatumumab FDA Link 11/2018
1	Therapeutic UsesIBA 01/2018
1	FlavonoidsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	wogoninIBA 01/2018

Therapy/Procedure

41	Therapeutics 01/2022 - 01/2002
20	Stem Cell Transplantation 01/2018 - 01/2002
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
11	Immunotherapy 01/2021 - 06/2002
10	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2003
8	Transplantation 01/2018 - 01/2002
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2008 - 01/2003
3	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 11/2012
1	Neoadjuvant Therapy 10/2020
1	Adjuvant Radiotherapy 10/2020